Xiaoling Cui Selected Research

s-formylglutathione hydrolase

1/2022

Activation of Esterase D by FPD5 Inhibits Growth of A549 Lung Cancer Cells via JAB1/p53 Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoling Cui Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 12/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Arteriosclerosis 01/2021
1	Fatty Liver 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Atherosclerosis 01/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	End Stage Liver Disease 04/2018
1	Hepatitis B 04/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2018

Drug/Important Bio-Agent (IBA)

2	CholesterolIBA 01/2021 - 01/2020
1	Hypochlorous Acid (Hypochlorite)IBA 01/2022
1	s-formylglutathione hydrolaseIBA 01/2022
1	Annexin A7 (Synexin)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Threonine (L-Threonine)FDA Link 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	AlbuminsIBA 04/2018
1	Alanine Transaminase (SGPT)IBA 04/2018
1	BilirubinIBA 04/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2018

Therapy/Procedure

1	Aftercare (After-Treatment) 04/2018
1	Transplantation 04/2018